Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/7/14  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Gary E. Frashier

Wrong Gary E. Frashier?

President and Principal

Local Address: San Antonio, Texas, United States
Management Associates

Employment History

Board Memberships and Affiliations


  • MBA
  • M.S. , Management
    Massachusetts Institute of Technology
  • B.S. , Chemical Engineering
    Texas Tech University
93 Total References
Web References
Gary E. ..., 7 Feb 2014 [cached]
Gary E. Frashier
"StemBioSys has done an excellent job developing its unique stem cell technology. The company is ready to move to the next level." - Gary E. Frashier
Gary Frashier's skill in the development and commercialization of life sciences technologies and companies is evident in his long list of highly productive investment rounds and profitable exits.
As CEO of OSI Pharmaceuticals he oversaw the development of Tarceva, a cancer drug eventually marketed by Roche and Genentech and currently generating $1.7 billion in annual sales. OSI was acquired for $4 billion in 2010 and in addition Mr. Frashier has raised more than $250 million in equity and other sources for a wide variety of life science companies.
His executive leadership experience includes CEO and president positions with Millipore Corp., Waters Corp. and Genex Corp. Mr. Frashier has founded or co-founded several biotechnology companies including Merrimack Pharmaceuticals, Eutropics and Apex BioVentures Acquisition Corp. He serves as a director or advisor with of many of these and other life science companies.
Mr. Frashier is a strategic partner with SV Life Sciences, a major venture capital company. He also serves as president and principal of Management Associates.
Mr. Frashier holds a B.S. in chemical engineering from Texas Tech University and an M.B.A. from the Massachusetts Institute of Technology.
America Stem Cell, 4 Feb 2012 [cached]
Gary Frashier, M.B.A Executive Chairman of the Board & Co-Program/Project Team Leader for the ASC 101 Development Program
Gary is the President and Principal of Management Associates and brings extensive experience in life science company transactions and commercial operations. Prior to founding Management Associates in 1999, Mr. Frashier served as President and Chief Executive Officer of OSI Pharmaceuticals, a drug discovery company, from 1990 through 1998, and also as its Chairman of the Board from 1997 to 2000. During his tenure at OSI, the leading cancer drug "Tarceva" was discovered by OSI and it is now sold together with Genentech and Roche. Gary was instrumental in establishing strategic alliances with Pfizer, Hoechst, Sankyo, Roche and American Home Products and raised over $150 million from a combination of equity financings, grant awards, milestone payments and up-front fees.
..., 19 Dec 2013 [cached]
Gary E. Frashier, age ..., 19 April 2011 [cached]
Gary E. Frashier, age 74. Mr. Frashier has served as a director of Achillion since March 2008 and currently serves as chair of our compensation committee and as a member of our nominating and corporate governance committee. Mr. Frashier, through his company Management Associates, has been a strategic consultant to emerging growth companies in the life sciences field since 2000. From 1990 until September 1998, he served as Chief Executive Officer of OSI Pharmaceuticals, Inc., a biotechnology company, and from January 1997 until September 2000, as its Chairman of the Board. From 1987 until 1990, he served as President and CEO of Genex Corporation, a protein engineering company, and from 1984 until 1987, as Chairman and CEO of Continental Water Systems, Inc., a manufacturer and marketer of equipment to produce high purity water used by the
Mr. Frashier also served as Executive Vice President of Millipore Corporation, a provider of products and services to biopharmaceutical, manufacturing, clinical, analytical and research laboratories, and as President of Millipore’s Waters Associates subsidiary. Mr. Frashier also serves on the Board of Directors of Alseres Pharmaceuticals, Inc., Tekmira Pharmaceuticals Corp., and Apex Bioventures, Inc., a special purpose acquisition company, as well as privately-held American Stem Cell, Inc. Mr. Frashier received a B.S in Chemical Engineering from Texas Tech University and received his M.B.A. from the Massachusetts Institute of Technology. Mr. Frashier’s qualifications include extensive managerial, manufacturing and merger and acquisition experience as a chief executive officer of multiple life sciences industry companies. As a director with several emerging technology companies, and as a consultant in the industry, Mr. Frashier also provides extensive experience in compensation management, alliance management and strategy development, all of which enhances his value on our Board.
Gary E. ..., 15 June 2008 [cached]
Gary E. Frashier
Chief Financial Officer, Executive Vice President, Secretary, Director
Apex Bioventures Acquisition Corp
Other People with the name "Frashier":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.